# β-hydroxybutyrate, Glucose Metabolism and Prediabetes

> **NCT03889210** · NA · COMPLETED · sponsor: **University of Auckland, New Zealand** · enrollment: 18 (actual)

## Conditions studied

- PreDiabetes

## Interventions

- **OTHER:** HVMN Ketone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03889210
- **Lead sponsor:** University of Auckland, New Zealand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-08-16
- **Final completion:** 2019-08-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889210, "β-hydroxybutyrate, Glucose Metabolism and Prediabetes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03889210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
